Preferred Prescription, Inc.
USPTO PatentsView assignee record - 16 granted patents across 7 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Preferred ranks #18,009 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 7 technology areas.
- #18,009
- of 49,997 US assignees by volume
- Top 22%
- by Innovation Score (46.1/100)
- 11.6
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R18009 · US Corporation #18,009 · 16 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 16 grants
- MID-PACK #18,009/49,997
- PHOTO-FINISH Plastic Omnium NEW…
- CPC-NARROW A61F · 7 areas
- INNOV-PAR 46.1/100
- CLAIMS-PAR 11.6 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2022–2025 · 4y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Plastic Omnium NEW Energies France (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Preferred’s 46.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Preferred
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Preferred Prescription · this assignee
Preferred Prescription · this assignee
46 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Preferred's Innovation Score is 46.1/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Preferred?
Each dot is one of Preferred’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Preferred’s own 11.6 claims/patent is at or below the 14.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Preferred's grants concentrate
Preferred Prescription, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 93.8% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2024 (8 grants) versus a trough of 1 in 2022. By volume, Preferred sits between Plastic Omnium NEW Energies France and Pulsar Vascular, Inc..
Preferred's three-year grant acceleration
Preferred Prescription, Inc. shows 14 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Preferred's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Plastic Omnium NE…
Plastic Omnium NEW Energies France
16 patents
- PLX
PLX, Inc.
16 patents
- Polin SU Parklari…
Polin SU Parklari VE Havuz Sistemleri Anonim Sirketi
16 patents
- Prada
Prada S.A.
16 patents
- Premier Tech L TÉE
Premier Tech Technologies L TÉE
16 patents
- Prinoth
Prinoth Ltd.
16 patents
- PSJ International
PSJ International Ltd.
16 patents
- Pulsar Vascular
Pulsar Vascular, Inc.
16 patents
- Preferred Prescri… ◀
Preferred Prescription, Inc.
16 patents
What this shows Preferred holds 16 patents at rank #17,992, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Preferred
By rank, the assignees closest to #17,992 in granted patent volume.
- Plastic Omnium NEW Energies France #17,988 · 16 patents
- PLX, Inc. #17,989 · 16 patents
- Polin SU Parklari VE Havuz Sistemleri Anonim Sirketi #17,990 · 16 patents
- Prada S.A. #17,991 · 16 patents
- Premier Tech Technologies L TÉE #17,993 · 16 patents
- Prinoth Ltd. #17,994 · 16 patents
- PSJ International Ltd. #17,995 · 16 patents
- Pulsar Vascular, Inc. #17,996 · 16 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Preferred's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Preferred's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 1 | 6.3% |
| 2023 | 5 | 31.3% |
| 2024 | 8 | 50.0% |
| 2025partial year | 2 | 12.5% |
Which technologies does Preferred Prescription, Inc. patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Preferred Prescription, Inc.'s patent record in context - here's where to go next.
- Preferred Prescription, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 93.8% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #18,009 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Preferred Prescription, Inc. against Plastic Omnium NEW Energies France, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 46.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.